Entities

Preemadonna develops connected beauty hardware and creative software. Its Nailbot device prints digital images, emojis and custom artwork directly onto fingernails, supported by a community of creators.

Orakl Oncology combines patient-derived tumour organoids with artificial intelligence to help pharmaceutical and biotechnology companies discover and develop cancer treatments. It grows living models of patients’ tumours, tests their responses to drugs, and links those results with clinical histories, genomic data and medical imaging. Its O-Predict platform helps anticipate treatment response and clinical-trial outcomes, while O-Target identifies potential targets for new medicines. A spin-off from Gustave Roussy, it works with hospitals to build patient-matched biological and clinical datasets, with programmes including colorectal, pancreatic and KRAS-mutant cancers.

Provides cloud infrastructure for AI workloads, combining GPU computing, AI-oriented data centers, orchestration and inference services.

ROME Therapeutics developed medicines by studying repetitive, noncoding portions of the human genome. Its computational discovery platform identified disease-associated repeat elements and programs targeting LINE-1 reverse transcriptase, with applications in autoimmune disease, cancer and neurodegeneration. Its independent operations had wound down before January 2026, when it had become a wholly owned subsidiary of Pretzel Therapeutics, which continues access to its science and intellectual property.

Dusty Robotics, Inc. is a Delaware construction robotics company founded in 2018 by Tessa Lau and Philipp Herget, with its principal place of business in Mountain View, California. Its FieldPrint Platform combines autonomous mobile FieldPrinter robots, BIM-to-field software, equipment training and technical support. FieldPrinter transfers building designs and coordinated trade information from Revit/AutoCAD models onto jobsite floors, helping teams coordinate layout, inspect revisions and communicate design intent. The business combines precision robotics, metrology and construction workflow software; performance and accuracy figures remain developer-reported. It serves construction contractors and trade teams, including builders of healthcare facilities, rather than supplying a clinical neuroscience treatment. The own 2025 services agreement names the exact legal corporation and provides access to equipment under service/work orders without transferring equipment ownership. Issuer releases confirm USD5M seed financing in 2019 and USD16.5M Series A in 2021; Scale reports leading the USD45M Series B in 2022. Cumulative totals are not additional funding events. The current site publishes no comprehensive employee or board directory; founders and source-qualified public technical contributors are recorded separately from an assumed complete workforce.

Developer of AI demand forecasting and replenishment software for perishable grocery products. Its platform helps retailers automate ordering, improve fresh-food availability and reduce inventory waste.

Digital-health company providing a mobile tinnitus support program alongside care from hearing specialists. Its app offers audio-based education, exercises drawing on cognitive behavioral techniques, calming soundscapes, mindfulness and sleep support, while providers can review patient progress. The current company site describes the app as supporting behavioral coping skills rather than diagnosing or curing disease; its program is being studied in independent clinical research. Founded by doctors with personal experience of tinnitus.